ovarian cancer

Roundup: ANDHealth receives $14M in gov't funding, Zhongchao launches ovarian cancer patient management platform and more briefs

By Adam Ang 06:40 am August 27, 2021

Australian digital health backer ANDHealth scores $14M in government funding ANDHealth, a digital health commercialisation organisation in Australia, has secured A$19.75 million ($14.3 million) in government funding to support its programme for small and medium enterprises. It received the funding under the federal government's Medical Research Future Fund – Early Stage Translation and...

AstraZeneca taps Voluntis for ovarian cancer treatment companion app

By Jonah Comstock 11:36 am December 7, 2015

French companion app company Voluntis has partnered with AstraZeneca to develop an app for women undergoing treatment for ovarian cancer. Specifically, the app will help patients and clinicians manage the side effects of a combination therapy of the drugs cediranib and olaparib, which can cause hypertension and diarrhea. "AstraZeneca has a strong focus on the use of companion devices in drug...